The chemical class termed PP6 Inhibitors, in reference to the PPP6C gene, represents a group of compounds that target the protein phosphatase 6 (PP6) catalytic subunit, either through direct interaction or indirect modulation. These inhibitors are of significant interest in research, particularly in understanding the biochemical and cellular functions of PP6. PP6, encoded by the PPP6C gene, is a serine/threonine phosphatase implicated in several cellular processes, including cell cycle regulation, DNA repair, and signal transduction. It plays a critical role in maintaining cellular homeostasis by dephosphorylating various substrates, thus influencing their activity, localization, and function. The inhibition of PP6 provides a means to study these processes in greater detail, offering insights into the intricate mechanisms of cellular regulation.
Direct inhibitors of PP6 would typically bind to the catalytic subunit of the enzyme, inhibiting its phosphatase activity. This inhibition can occur through the binding of the inhibitor to the active site, thereby substrate access, or by inducing conformational changes that render the enzyme catalytically inactive. The study of direct inhibitors is crucial for understanding the structure-function relationship of PP6, as well as for identifying its specific substrates and regulatory mechanisms. Indirect inhibitors, on the other hand, affect PP6 activity without directly interacting with the phosphatase itself. These compounds might target signaling pathways or proteins that regulate the expression, localization, or activity of PP6. For instance, inhibitors of kinases that phosphorylate PP6 can alter its activity indirectly by changing its phosphorylation state. Similarly, compounds that disrupt cellular structures or processes that are essential for PP6 function can also serve as indirect inhibitors. In research settings, PP6 inhibitors are valuable for dissecting the roles of PP6 in various cellular contexts. By modulating PP6 activity, scientists can explore the consequences of altered phosphorylation on cellular functions such as signal transduction, gene expression, and cell cycle progression. These studies contribute to a deeper understanding of the regulatory networks in which PP6 is involved and its role in maintaining cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $160.00 $750.00 | 59 | |
Inhibits PP1 and PP2A, potentially impacting PP6-related pathways due to similar phosphatase activity. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $81.00 $260.00 | 6 | |
Inhibits PP2A and other phosphatases, could indirectly influence PP6 activity. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $48.00 $199.00 | 1 | |
PP2A inhibitor, may affect signaling pathways involving PP6. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $260.00 | 9 | |
Preferentially inhibits PP2A and PP4, potentially impacting PP6 in related pathways. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits protein phosphatase activity, potentially affecting PP6 indirectly. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Inhibits calcineurin (PP2B), could indirectly affect PP6 in signal transduction pathways. | ||||||
LB-100 | 1632032-53-1 | sc-507368 | 10 mg | $330.00 | ||
A small molecule inhibitor of PP2A, could have effects on PP6 indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, could affect cellular processes involving PP6 indirectly. | ||||||